Literature DB >> 33004659

SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March-May 2020.

Michael Edelstein1, Chinelo Obi2, Meera Chand2, Susan Hopkins2, Kevin Brown2, Mary Ramsay2.   

Abstract

BACKGROUND: The UK has been one of the European countries most affected by COVID-19 pandemic. The UK implemented a lockdown in March 2020, when testing policy at the time was focusing on hospitalised cases. Limited information is therefore available on the impact of the lockdown on point prevalence in the community. We assessed COVID-19 point prevalence in London between early April and early May 2020, which approximately reflect infection around the time of the lockdown and 3-5 weeks into lockdown.
METHODS: We tested 1064 participants of a community surveillance cohort for acute COVID-19 infection using PCR in London in April and May 2020 and described positivity as well as characteristics and symptoms of the participants.
RESULTS: Point prevalence decreased from 2.2% (95% CI 1.4 to 3.5) in early April to 0.2% (95% CI 0.03 to 1.6) in early May. 22% of those who tested positive in April were asymptomatic. Extrapolation from reports of confirmed cases suggest that 5-7.6% of total infections were confirmed by testing during this period.
CONCLUSION: COVID-19 point prevalence in the community sharply decreased after lockdown was implemented. This study is based on a small sample and regular seroprevalence studies are needed to better characterise population-level immunity. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Epidemics; communicable diseases; control of diseases

Year:  2020        PMID: 33004659     DOI: 10.1136/jech-2020-214730

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  6 in total

1.  Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.

Authors:  Diana Buitrago-Garcia; Aziz Mert Ipekci; Leonie Heron; Hira Imeri; Lucia Araujo-Chaveron; Ingrid Arevalo-Rodriguez; Agustín Ciapponi; Muge Cevik; Anthony Hauser; Muhammad Irfanul Alam; Kaspar Meili; Eric A Meyerowitz; Nirmala Prajapati; Xueting Qiu; Aaron Richterman; William Gildardo Robles-Rodriguez; Shabnam Thapa; Ivan Zhelyazkov; Georgia Salanti; Nicola Low
Journal:  PLoS Med       Date:  2022-05-26       Impact factor: 11.613

2.  Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength.

Authors:  Noah A Haber; Emma Clarke-Deelder; Avi Feller; Emily R Smith; Joshua A Salomon; Benjamin MacCormack-Gelles; Elizabeth M Stone; Clara Bolster-Foucault; Jamie R Daw; Laura Anne Hatfield; Carrie E Fry; Christopher B Boyer; Eli Ben-Michael; Caroline M Joyce; Beth S Linas; Ian Schmid; Eric H Au; Sarah E Wieten; Brooke Jarrett; Cathrine Axfors; Van Thu Nguyen; Beth Ann Griffin; Alyssa Bilinski; Elizabeth A Stuart
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

3.  Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London.

Authors:  Luke B Snell; Wenjuan Wang; Adela Alcolea-Medina; Themoula Charalampous; Rahul Batra; Leonardo de Jongh; Finola Higgins; Gaia Nebbia; Yanzhong Wang; Jonathan Edgeworth; Vasa Curcin
Journal:  BMJ Open       Date:  2022-02-08       Impact factor: 2.692

4.  Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.

Authors:  P Simmonds
Journal:  mBio       Date:  2020-10-30       Impact factor: 7.867

5.  Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic.

Authors:  Javier Martin; Dimitra Klapsa; Thomas Wilton; Maria Zambon; Emma Bentley; Erika Bujaki; Martin Fritzsche; Ryan Mate; Manasi Majumdar
Journal:  Viruses       Date:  2020-10-09       Impact factor: 5.048

6.  Influence of state reopening policies in COVID-19 mortality.

Authors:  Ka-Ming Tam; Nicholas Walker; Juana Moreno
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.